Equillium (EQ) Total Current Liabilities (2017 - 2026)
Equillium (EQ) reported Total Current Liabilities of $3.3 million for Q1 2026, down 44.27% year-over-year from $6.0 million in Q1 2025, and up 14.01% quarter-over-quarter from $2.9 million in Q4 2025.
Equillium (EQ) Total Current Liabilities (2017 - 2026) Analysis & Trends
Equillium (EQ) has 10 years of Total Current Liabilities data on file, last reported at $3.3 million in Q1 2026.
- Total Current Liabilities for Q1 2026 came in at $3.3 million, down 44.27% year-over-year; the trailing twelve-month figure through Mar 2026 was $3.3 million (down 44.27% YoY), and the FY2025 annual result was $2.9 million, down 53.84% from the prior year.
- Total Current Liabilities climbed to $3.3 million in Q1 2026 per EQ's latest filing, from $2.9 million in the prior quarter.
- Over five years, Total Current Liabilities peaked at $32.0 million in Q4 2022 and troughed at $2.9 million in Q4 2025.
- A 5-year average of $15.9 million and a median of $14.9 million in 2022 frame the typical range for Total Current Liabilities.
- The sharpest annual moves came in 2022 and 2024: Total Current Liabilities soared 259.37% in 2022, then slumped 76.95% in 2024.
- A 5-year view of Total Current Liabilities shows it stood at $32.0 million in 2022, then dropped by 13.94% to $27.6 million in 2023, then tumbled by 76.95% to $6.4 million in 2024, then tumbled by 53.84% to $2.9 million in 2025, then grew by 14.01% to $3.3 million in 2026.
- Business Quant data shows EQ's Total Current Liabilities at $3.3 million in Q1 2026, $2.9 million in Q4 2025, and $3.1 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | 1.70 Mn |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 16.35 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 636.40 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | 13.42 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 3.88 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | 72.86 Mn |
| 10 | Equillium | 293.17 Mn | 232.78 Mn | - | 3.35 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 3.35 Mn |
| Dec 31, 2025 | 2.93 Mn |
| Sep 30, 2025 | 3.09 Mn |
| Jun 30, 2025 | 7.23 Mn |
| Mar 31, 2025 | 6.00 Mn |
| Dec 31, 2024 | 6.36 Mn |
| Sep 30, 2024 | 11.06 Mn |
| Jun 30, 2024 | 20.17 Mn |
| Mar 31, 2024 | 22.21 Mn |
| Dec 31, 2023 | 27.57 Mn |
| Sep 30, 2023 | 28.20 Mn |
| Jun 30, 2023 | 25.22 Mn |
| Mar 31, 2023 | 32.02 Mn |
| Dec 31, 2022 | 32.04 Mn |
| Sep 30, 2022 | 14.93 Mn |
| Jun 30, 2022 | 15.19 Mn |
| Mar 31, 2022 | 13.11 Mn |
| Dec 31, 2021 | 8.92 Mn |
| Sep 30, 2021 | 7.78 Mn |
| Jun 30, 2021 | 4.98 Mn |